The University of California San Diego School of Medicine has launched the Institute for Diabetes and Metabolic Health (IDMH), a new cross-disciplinary, collaborative effort to address one of the nation’s leading public health threats.
Cancer stem cells are like zombies — even after a tumor is destroyed, they can keep coming back. These cells have an unlimited capacity to regenerate themselves, making more cancer stem cells and more tumors. Researchers at University of California San Diego School of Medicine have now unraveled how pre-leukemic white blood cell precursors become leukemia stem cells.
Excitement was palpable at UC San Diego’s inaugural Triton Entrepreneur Night as student entrepreneurs, alumni, staff, and community supporters gathered for demos and presentations from the latest crop of student-driven innovations.
Students and researchers at all stages of their academic careers went head-to-head recently, competing for $100k in prizes at the 10th annual UC San Diego Entrepreneur Challenge.
To better understand the pathogenic bacteria Staphylococcus aureus and develop more effective treatments, University of California San Diego researchers examined the Staph “pan-genome” — the genomes of 64 different strains that differ in where they live, the types of hosts they infect and their antibiotic resistance profiles. This effort, published June 6 by PNAS, places all Staph genes into one of two categories: the core genome or the dispensable genome.
In a meta-analysis of hundreds of clinical trials involving thousands of patients, researchers at University of California San Diego School of Medicine report that therapeutic approaches using precision medicine, which emphasizes the use of individual genetics to refine cancer treatment, showed improved response and longer periods of disease remission, even in phase I trials.
La Jolla Light, April 15
U.S. News & World Report, April 9
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
